AUNP 12

Pricing Availability   Qty
说明: Peptide inhibitor of the PD-1 signaling pathway
纯度: ≥95% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for AUNP 12

AUNP 12 is an immune checkpoint modulator targeting the programmed cell death 1 (PD-1) signaling pathway. It inhibits the interaction between PD-1 and its ligands, PD-L1 and PD-L2. In the mouse splenocyte assay system, AUNP 12 rescues proliferation (EC50 values are 17 and 16 nM for PD-L1 and PD-L2, respectively) and enhances T-cell activity by restoring IFNγ release inhibited by PD-L1 and PD-L2 (EC50 values are 49 nM and 51 nM respectively). In a mouse Renca renal cell carcinoma model, AUNP 12 shows an additive antitumor effect when combined with Cyclophosphamide (Cat. No. 4091).

技术数据 for AUNP 12

分子量 3261.56
公式 C142H226N40O48
序列 SNTSESFKFRVTQLAPKAQIKE SNTSESF*

(Modifications: Amide bridge= 8-7*, Glu-22 = C-terminal amide)

储存 Store at -20°C
纯度 ≥95% (HPLC)
CAS Number 1353563-85-5
PubChem ID 154701623
InChI Key ZBJUUYIGBAQYBN-QKLNNLIKSA-N
Smiles OC(CC[C@@H](C(N)=O)NC([C@H](CCCCN)NC([C@H]([C@H](CC)C)NC([C@@H](NC([C@@H](NC([C@H](CCCCN)NC([C@@H]1CCCN1C([C@@H](NC([C@@H](NC([C@@H](NC([C@@]([H])(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC2=CC=CC=C2)NC([C@H](CO)NC([C@H](CCC(O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CO)N)=O)CC(N)=O)=O)[C@@H](C)O)=O)CO)=O)=O)=O)=O)CCCCNC([C@@H](NC([C@H](CO)NC([C@@H](NC([C@H](CO)NC([C@H]([C@@H](C)O)NC([C@H](CC(N)=O)NC([C@H](CO)N)=O)=O)=O)=O)CCC(O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=CC=C4)=O)CCCNC(N)=N)=O)C(C)C)=O)[C@@H](C)O)=O)CCC(N)=O)=O)CC(C)C)=O)C)=O)=O)=O)C)=O)CCC(N)=O)=O)=O)=O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for AUNP 12

溶解性 Soluble to 2 mg/ml in water

参考文献 for AUNP 12

参考文献是支持产品生物活性的出版物。

Omstead et al (2022) CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model. Carcinogenesis 43 842 PMID: 35552655

Sasikumar et al (2019) A rationally designed peptide antagonist of the PD-1 signaling pathway as an immunomodulatory agent for cancer therapy. Mol.Cancer Ther. 18 1081 PMID: 31015307

Zhan et al (2016) From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway. Drug Discov.Today 21 1027 PMID: 27094104


If you know of a relevant reference for AUNP 12, please let us know.

按产品操作查看相关产品

查看全部 Immune Checkpoint Inhibitors

关键词: AUNP 12, AUNP 12 supplier, AUNP12, immune, checkpoint, programmed, cell, death, 1, PD-1, PD-L1, PD-L2, IFN, gamma, Interferon, Other, Apoptosis, Immune, Checkpoints, 7831, Tocris Bioscience

篇 AUNP 12 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 AUNP 12 的引用文献。 您是否知道使用了 Tocris AUNP 12 的优秀论文? 请告知我们.

AUNP 12 的评论

目前没有该产品的评论。 Be the first to review AUNP 12 and earn rewards!

Have you used AUNP 12?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.